Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 2Venous Thromboembolism 1Supratentorial Neoplasms 1Recurrence 1Ovarian Neoplasms 1Neoplasm Metastasis 1Glioma 1Endometrial Neoplasms 1Dyskinesias 1Diarrhea 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 7Cyclophosphamide 7Busulfan 7Whole-Body Irradiation 6Melphalan 6Radiofrequency Ablation 5Mycophenolic Acid 5Filgrastim 5Antilymphocyte Serum 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Methotrexate 4Etoposide 4Drug Therapy 4Cisplatin 4fludarabine 3Radiosurgery 3Injections 3Hepatectomy 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2lenvatinib 2Vinblastine 2Videotape Recording 2Thiotepa 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recurrence × Long-Term Synaptic Depression × Clear all
NCT04489706 2020-07-28

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Ruijin Hospital

Phase NA Unknown
20 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡